Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).
Minutolo, Roberto
Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN). [electronic resource] - Journal of nephrology Oct 2018 - 685-712 p. digital
Publication Type: Journal Article; Practice Guideline
1724-6059
10.1007/s40620-018-0523-1 doi
Antiviral Agents--adverse effects
Consensus
Evidence-Based Medicine
Hepacivirus--drug effects
Hepatitis C, Chronic--diagnosis
Humans
Kidney Transplantation--adverse effects
Prevalence
Renal Dialysis--adverse effects
Renal Insufficiency, Chronic--diagnosis
Risk Assessment
Risk Factors
Treatment Outcome
Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN). [electronic resource] - Journal of nephrology Oct 2018 - 685-712 p. digital
Publication Type: Journal Article; Practice Guideline
1724-6059
10.1007/s40620-018-0523-1 doi
Antiviral Agents--adverse effects
Consensus
Evidence-Based Medicine
Hepacivirus--drug effects
Hepatitis C, Chronic--diagnosis
Humans
Kidney Transplantation--adverse effects
Prevalence
Renal Dialysis--adverse effects
Renal Insufficiency, Chronic--diagnosis
Risk Assessment
Risk Factors
Treatment Outcome